All articles tagged with #case western reserve university
A study by Case Western Reserve University found that diabetes drugs Wegovy and Ozempic, which contain semaglutide, significantly reduce the risk and recurrence of alcohol-use disorder by 50%-56%. This discovery suggests a potential new treatment for AUD, though further clinical trials are needed to confirm these findings.
Researchers at Case Western Reserve University found that the weight loss and diabetes drugs Wegovy and Ozempic, both GLP-1 receptor agonists, may reduce the risk of colorectal cancer. A study using electronic health records showed a 44% reduction in colorectal cancer incidence in patients treated with GLP-1 RA compared to those treated with insulin, and a 25% reduction compared to those treated with Metformin. The protective effect was observed in patients of all body types, suggesting the need for further clinical trials to explore the potential of these medications in preventing various types of cancer associated with obesity and diabetes.